
US Overdose Capital Baltimore On Long Road To Recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it." Adam Trionfo, Therapeutic Support Specialist, at Our Daily Bread Employment Center (ODBC) with the Catholic Charities, hands out supplies and a box of Narcan to to men in Baltimore, Maryland AFP Dexter Daniel, a Peer Recover Coach at Our Daily Bread Employment Center (ODBC) with the Catholic Charities, holds boxes of Narcan to hand out on a street in Baltimore, Maryland on June 10, 2025 AFP Genese Hubbard, a Peer Recover Coach at Our Daily Bread Employment Center (ODBC) with the Catholic Charities, hands out supplies and Narcan to an unhoused women living in an alley in Baltimore, Maryland on June 10, 2025 AFP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Int'l Business Times
a day ago
- Int'l Business Times
US Overdose Capital Baltimore On Long Road To Recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore. The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan. The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022. "Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP. On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization. The man takes it with one hand, as he awkwardly hides a syringe behind his back. Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building. These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime. Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles. And last year, the New York Times dubbed the city the "American overdose capital." Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl. Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore. The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023. The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem. "We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center. Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said. In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries. The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said. "The drug supply has less potent fentanyl and has additives that are less likely to cause overdose." Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection. The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors. "I'm not saying people are going to stop using," Atiba said. "That's not even our goal." "It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it." Adam Trionfo, Therapeutic Support Specialist, at Our Daily Bread Employment Center (ODBC) with the Catholic Charities, hands out supplies and a box of Narcan to to men in Baltimore, Maryland AFP Dexter Daniel, a Peer Recover Coach at Our Daily Bread Employment Center (ODBC) with the Catholic Charities, holds boxes of Narcan to hand out on a street in Baltimore, Maryland on June 10, 2025 AFP Genese Hubbard, a Peer Recover Coach at Our Daily Bread Employment Center (ODBC) with the Catholic Charities, hands out supplies and Narcan to an unhoused women living in an alley in Baltimore, Maryland on June 10, 2025 AFP


Int'l Business Times
5 days ago
- Int'l Business Times
RFK Jr Accused of 'Lying Under Oath' After Firing Entire Vaccine Advisory Committee: 'Charge RFK Jr. With Perjury'
Health Secretary Robert F. Kennedy Jr. is being accused of lying under oath before Congress after announcing that he will be "retiring" all members of a vaccine advisory committee. Kennedy took to the Wall Street Journal, publishing an op-ed in which he revealed that he made the decision to remove all 17 members of the Advisory Committee on Immunization Practices. The Committee, which consisted of independent vaccine experts, was often tasked with advising the Centers for Disease Control and Prevention. "Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028," Kennedy wrote, defending his decision. Social media users reacted with outrage at Kennedy's actions, stating that he previously lied to Congress when he insisted that he was not anti-vaccine at his confirmation hearing. "Scary stuff. He said he wouldn't do this during his confirmation hearing," said one user. "Oh great @BillCassidy! Talking to RFK Jr seems like a perfectly good plan. How bout impeach the liar?" said another, responding to a post from Senator Bill Cassidy acknowledging fears of officials who oppose vaccinations being tapped to serve on the renewed ACIP. "It is time to fire @SecKennedy and prosecute him. He is intentionally harming Americans," said a third. "@RobertKennedyJrYou're a f--king liar and a dumbass. Why should anybody take advice from an uninformed, self righteous, opportunistic skank like you? F--k you, RFK Jr," said a fourth. "Let's play RFK's confirmation testimony where he swore this was not his plan. Lying under oath is perjury," another outraged user wrote. "This is ignorant and not true! Vaccines were one of the greatest health advancements in the 20th century! Vaccines saved countless lives. You are harming Americans with your lack of scientific knowledge and blatant ignorance. Shame in you!" added another. Others called for officials to "charge RFK Jr. with perjury." "The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine. It has never recommended against a vaccine—even those later withdrawn for safety reasons," RFK Jr. continued in the op-ed. "It has failed to scrutinize vaccine products given to babies and pregnant women. To make matters worse, the groups that inform ACIP meet behind closed doors, violating the legal and ethical principle of transparency crucial to maintaining public trust." Kennedy has made numerous other moves suggesting that he is not an advocate of vaccines, including forcing the resignation of the Food and Drug Administration's top vaccine scientist, hiring a vaccine skeptic who was disciplined for practicing medicine unlicensed to review CDC vaccine safety data and undermined the importance of a measles vaccine during one of the worst outbreaks in American history. "Today's action to remove the 17 sitting members of ACIP undermines that trust and upends a transparent process that has saved countless lives," Bruce A. Scott, the president of the American Medical Association, said in a statement. "With an ongoing measles outbreak and routine child vaccination rates declining, this move will further fuel the spread of vaccine-preventable illnesses." Originally published on Latin Times


DW
04-06-2025
- DW
Secret leprosy infected the Americas before European arrival – DW – 06/04/2025
European colonizers were thought to have brought leprosy to the Americas, but a new study reveals it existed there for thousands of years and spread by a recently discovered bacteria species. What to know: Leprosy is one of the oldest human diseases and originated in Eurasia or Africa. A new study has found a different species of leprosy-causing bacteria existed in the Americas before European settlement. Scientists once believed Europeans brought leprosy to the American continents via infection from the bacterial species Mycobacterium leprae. But now a new study published in the journal Science reveals that a different form of leprosy-causing bacteria — called Mycobacterium lepromatosis — was already circulating in the Americas for at least one thousand years. Leprosy was therefore already affecting American indigenous peoples well before European colonization. For years, it was believed Mycobacterium leprae bacteria were the only cause of leprosy. That changed with the discovery of a new leprosy-causing Mycobacterium in 2008. Image: public domain Mycobacterium lepromatosis in America The study authors analyzed more than 800 samples taken from ancient remains in Canada and Argentina. The genomes of the bacteria taken from the samples were reconstructed, analyzed, and dated. Comparisons between the samples showed the bacterial genomes were of distinctive branches of the lepromatosis species at each end of the continent. However, they remained genetically similar. This suggested that the bacteria species had spread rapidly across the Americas, probably covering the landmass in just a few hundred years. Leprosy is caused by two bacteria species, not one. Leprosy is an ancient disease Leprosy has been infecting humans for thousands of years. Skeletal records from 2,000BCE have been found in India with traces of the disease caused by Mycobacterium leprae. These are matched by textual records of leprosy cases in ancient literature from Indian, Chinese and African civilizations, as well as stories in the Abrahamic religions. Often, these ancient descriptions associated the affliction with stigmas of immorality or ritual uncleanliness. But in 1874 the Norwegian doctor Gerhard Armauer Hansen discovered that leprosy was caused by the microscopic organism Mycobacterium leprae. In 2008, doctors in Mexico found another leprosy-causing bacteria species — Mycobacterium lepromatosis — in a leprosy patient. Before this, it was believed leprae was the only pathogen capable of causing the disease. Now both forms of the bacteria are known to cause it. Leprosy has been stigmatized around the world for thousands of years, but with quick medical treatment, its dangerous symptoms can be reduced Image: Nyein Chan Naing/dpa/picture alliance Europeans spread diseases, leprosy too Nicolas Rascovan, head of the Microbial Paleogenomics Unit at the Pasteur Institut in France led the investigation. He and his colleagues estimate lepromatosis and leprae diverged from a common ancestor about one million years ago. "The diversification happened probably independent of humans," Rascovan told DW. The arrival of the first European fleets to the Americas in 1492 marked the introduction of new diseases to the Americas. Leprosy — in the form of the leprae bacterium — was among them. Archaeological evidence has shown leprae migrated with human groups out of Africa and into Asia and Europe around 40,000 years ago. Its introduction to the Americas along with other diseases by Europeans devastated indigenous communities and intensified the impact of pathogens that were already circulating before colonization. The discovery of lepromatosis' longer history on the continent further highlights the diversity of pathogens and their complex relationship with humans throughout history, said Rascovan. "Europeans had a very important impact by bringing this new species [leprae] that was absent in America," he said. Indonesian leprosy survivors stepping over social stigmas To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Leprosy track and trace Rascovan hopes the presence of lepromatosis in the archeological record will improve understanding of pre-colonial disease, especially in the absence of written records. In addition, the study helps understand modern cases of leprosy, especially how it could make the jump from animals like squirrels to humans. "Our work is giving the kick start to really start analyzing, monitoring and understanding the diversity of natural reservoirs [disease carriers],' said Rascovan. He said monitoring the disease and preventing spillovers from animals to humans should be a priority. The disease is still prevalent today — 200,000 cases are reported each year globally. Brazil, India and Indonesia still report more than 10,000 new cases annually, according to WHO data. The disease presents as multiple numbing skin lesions. If left untreated, the disease can result in nerve damage, muscle weakness, paralysis and blindness. Today, leprosy can be treated with antibiotics, but ancient sufferers weren't so fortunate. Edited by: Fred Schwaller